Vanda Pharmaceuticals Inc.
DE ˙ DB ˙ US9216591084
5,17 € ↓ -0,02 (-0,39%)
2026-06-04
PREZZO DELLE AZIONI
SecurityDE:VM4 / Vanda Pharmaceuticals Inc.
InstitutionInvesco Ltd.
Latest Disclosed Ownership174,064 shares
Latest Disclosed Value $ 1,202,782
Invesco Ltd. reports 41.52% increase in ownership of VM4 / Vanda Pharmaceuticals Inc.

On May 12, 2026 - Invesco Ltd. filed a 13F-HR form disclosing ownership of 174,064 shares of Vanda Pharmaceuticals Inc. (DE:VM4) valued at $1,000,868 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 19, 2026 disclosing 122,995 shares of Vanda Pharmaceuticals Inc.. This represents a change in shares of 41.52% during the quarter. The current value of the position is $899,911 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F VANDA PHARMACEUTICALS COM 921659108 174,064 51,069 41.52 1,203 10.89 0.0000
2026-02-19 2025-12-31 13F VANDA PHARMACEUTICALS COM 921659108 122,995 -18,260 -12.93 1,085 53.98 0.0002
2025-11-13 2025-09-30 13F VANDA PHARMACEUTICALS COM 921659108 141,255 -30,909 -17.95 705 -13.30 0.0001
2025-08-13 2025-06-30 13F VANDA PHARMACEUTICALS COM 921659108 172,164 -32,800 -16.00 813 -13.62 0.0001
2025-05-12 2025-03-31 13F VANDA PHARMACEUTICALS COM 921659108 204,964 -23,384 -10.24 941 -14.00 0.0002
2025-02-13 2024-12-31 13F VANDA PHARMACEUTICALS COM 921659108 228,348 1,605 0.71 1,094 2.82 0.0002
2024-11-12 2024-09-30 13F VANDA PHARMACEUTICALS COM 921659108 226,743 -76,776 -25.30 1,063 -37.98 0.0002
2024-08-13 2024-06-30 13F VANDA PHARMACEUTICALS COM 921659108 303,519 -27,120 -8.20 1,715 26.22 0.0004
2024-05-14 2024-03-31 13F VANDA PHARMACEUTICALS COM 921659108 330,639 195,651 144.94 1,359 138.66 0.0003
2024-02-13 2023-12-31 13F VANDA PHARMACEUTICALS COM 921659108 134,988 -10,519 -7.23 570 -9.39 0.0001
2023-11-13 2023-09-30 13F VANDA PHARMACEUTICALS COM 921659108 145,507 -217,302 -59.89 629 -73.72 0.0002
2023-08-11 2023-06-30 13F VANDA PHARMACEUTICALS COM 921659108 362,809 -6,030 -1.63 2,391 -4.55 0.0006
2023-05-12 2023-03-31 13F VANDA PHARMACEUTICALS COM 921659108 368,839 9,594 2.67 2,504 -5.65 0.0007
2023-02-13 2022-12-31 13F VANDA PHARMACEUTICALS COM 921659108 359,245 55,631 18.32 2,655 -11.50 0.0008
2022-11-14 2022-09-30 13F VANDA PHARMACEUTICALS COM 921659108 303,614 -4,639 -1.50 2,999 -10.74 0.0010
2022-08-15 2022-06-30 13F VANDA PHARMACEUTICALS COM 921659108 308,253 -10,172 -3.19 3,360 -6.72 0.0010
2022-05-16 2022-03-31 13F VANDA PHARMACEUTICALS COM 921659108 318,425 11,587 3.78 3,602 -25.16 0.0009
2022-02-14 2021-12-31 13F VANDA PHARMACEUTICALS COM 921659108 306,838 -11,784 -3.70 4,813 -11.87 0.0012
2021-11-15 2021-09-30 13F VANDA PHARMACEUTICALS COM 921659108 318,622 -11,657 -3.53 5,461 -23.14 0.0014
2021-08-17 2021-06-30 13F VANDA PHARMACEUTICALS COM 921659108 330,279 8,979 2.79 7,105 47.22 0.0017
2021-05-17 2021-03-31 13F VANDA PHARMACEUTICALS COM 921659108 321,300 -5,425 -1.66 4,826 12.42 0.0013
2021-02-16 2020-12-31 13F VANDA PHARMACEUTICALS COM 921659108 326,725 -37,358 -10.26 4,293 22.06 0.0012
2020-11-16 2020-09-30 13F VANDA PHARMACEUTICALS COM 921659108 364,083 -1,443,707 -79.86 3,517 -82.99 0.0012
2020-08-14 2020-06-30 13F VANDA PHARMACEUTICALS COM 921659108 1,807,790 1,481,606 454.22 20,682 512.07 0.0074
2020-05-15 2020-03-31 13F VANDA PHARMACEUTICALS COM 921659108 326,184 -975,017 -74.93 3,379 -84.17 0.0014
2020-02-14 2019-12-31 13F VANDA PHARMACEUTICALS COM 921659108 1,301,201 -141,012 -9.78 21,352 11.48 0.0066
2019-11-14 2019-09-30 13F VANDA PHARMACEUTICALS COM 921659108 1,442,213 -78,970 -5.19 19,153 -10.64 0.0050
2019-08-14 2019-06-30 13F/A-1 VANDA PHARMACEUTICALS COM 921659108 1,521,183 24,525 1.64 21,434 -22.17 0.0055
2019-08-14 2019-06-30 13F VANDA PHARMACEUTICALS COM 921659108 1,521,183 -1,495,958 21,434
2019-05-15 2019-03-31 13F VANDA PHARMACEUTICALS COM 921659108 1,496,658 565,487 60.73 27,538 13.18 0.0093
2019-02-14 2018-12-31 13F VANDA PHARMACEUTICALS COM 921659108 931,171 898,114 2,716.86 24,331 3,105.67 0.0093
2018-11-14 2018-09-30 13F VANDA PHARMACEUTICALS COM 921659108 33,057 -1,188,092 -97.29 759 -96.74 0.0002
2018-08-14 2018-06-30 13F VANDA PHARMACEUTICALS COM 921659108 1,221,149 -69,487 -5.38 23,263 6.97 0.0077
2018-05-15 2018-03-31 13F VANDA PHARMACEUTICALS COM 921659108 1,290,636 1,290,636 21,747 0.0081
2018-02-14 2017-12-31 13F VANDA PHARMACEUTICALS COM 921659108 0 -409,835 -100.00 0 -100.00
2017-11-14 2017-09-30 13F VANDA PHARMACEUTICALS COM 921659108 409,835 391,659 2,154.81 7,336 2,378.38 0.0027
2017-08-14 2017-06-30 13F VANDA PHARMACEUTICALS COM 921659108 18,176 -65,754 -78.34 296 -74.81 0.0001
2017-05-15 2017-03-31 13F VANDA PHARMACEUTICALS COM 921659108 83,930 -404,095 -82.80 1,175 -84.90 0.0004
2017-02-14 2016-12-31 13F VANDA PHARMACEUTICALS COM 921659108 488,025 464,261 1,953.63 7,784 1,870.63 0.0026
2016-11-14 2016-09-30 13F VANDA PHARMACEUTICALS COM 921659108 23,764 11,487 93.57 395 188.32 0.0001
2016-08-15 2016-06-30 13F VANDA PHARMACEUTICALS COM 921659108 12,277 12,277 0.00 137 0.0001
2016-05-16 2016-03-31 13F VANDA PHARMACEUTICALS COM 921659108 0 -316,287 -100.00 0 -100.00
2016-02-16 2015-12-31 13F VANDA PHARMACEUTICALS COM 921659108 316,287 -623,745 -66.35 2,944 -72.24 0.0012
2015-11-16 2015-09-30 13F VANDA PHARMACEUTICALS COM 921659108 940,032 -82,573 -8.07 10,604 -18.29 0.0045
2015-08-14 2015-06-30 13F VANDA PHARMACEUTICALS COMMON 921659108 1,022,605 427 0.04 12,977 36.51 0.0051
2015-05-15 2015-03-31 13F VANDA PHARMACEUTICALS COMMON 921659108 1,022,178 0 0.00 9,506 -35.06 0.0037
2015-02-13 2014-12-31 13F VANDA PHARMACEUTICALS COMMON 921659108 1,022,178 -203,389 -16.60 14,638 15.07 0.0057
2014-11-14 2014-09-30 13F VANDA PHARMACEUTICALS COMMON 921659108 1,225,567 -127,487 -9.42 12,721 -41.89 0.0051
2014-08-14 2014-06-30 13F VANDA PHARMACEUTICALS COMMON 921659108 1,353,054 -131,091 -8.83 21,893 -9.23 0.0086
2014-05-15 2014-03-31 13F VANDA PHARMACEUTICALS COMMON 921659108 1,484,145 351,543 31.04 24,118 71.59 0.0098
2014-02-13 2013-12-31 13F VANDA PHARMACEUTICALS COMMON 921659108 1,132,602 6,114 0.54 14,056 13.95 0.0056
2013-11-13 2013-09-30 13F VANDA PHARMACEUTICALS COMMON 921659108 1,126,488 -400 -0.04 12,335 35.48 0.0054
2013-08-14 2013-06-30 13F VANDA PHARMACEUTICALS COMMON 921659108 1,126,888 1,126,888 9,105 0.0042
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.